The Indian drug regulator has flagged 49 samples of medicines, including Torrent Pharmaceuticals Ltd’s anti-hypertension drug Lorvas, for failing quality tests.
A change in the formula composition of several batches of the drug NATRILIX® 1.5 mg SR (indapamide) - coated tablet extended release, without prior knowledge of Anvisa, generated the suspension of the product.